AbbVie Inc. Press Releases

ABBV 
$60.5
*  
0.02
0.03%
Get ABBV Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading ABBV now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    ABBV After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting
2/26/2015 4:48:00 PM - PR Newswire


AbbVie Launches SigueElGuion.com to Educate Spanish-Speaking Americans about Hypothyroidism and the Importance of Dialogue between Patient and Healthcare Professional
2/26/2015 8:00:00 AM - PR Newswire


AbbVie to Present at Cowen 35th Annual Health Care Conference
2/25/2015 8:22:00 AM - PR Newswire


AbbVie to Present at Cowen 35th Annual Health Care Conference
2/25/2015 8:22:00 AM - PR Newswire


Results from AbbVie's Study of VIEKIRA PAK™ (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) in Chronic Hepatitis C Patients with HIV-1 Co-Infection (TURQUOISE-I) Published Online in JAMA; Sub-analyses to be Presented at the Annual Confere
2/23/2015 11:02:00 AM - PR Newswire


AbbVie Increases Quarterly Dividend
2/19/2015 12:12:00 PM - PR Newswire


AbbVie Submits New Drug Application in Japan for its Investigational, All-Oral, Treatment for Chronic Hepatitis C
2/11/2015 10:04:00 PM - PR Newswire


EPAM Systems, Inc. Announces Date for Fourth-Quarter and Full Year 2014 Earnings Release and Conference Call
2/3/2015 4:34:00 PM - GlobeNewswire


AbbVie Announces Top-line Results from Phase 3 Study of All-Oral Treatment for Hepatitis C in Japan
1/30/2015 6:00:00 PM - PR Newswire


AbbVie Reports Fourth-Quarter and Full-Year 2014 Financial Results
1/30/2015 7:47:00 AM - PR Newswire


AbbVie Innovation Center Opens at the University of Illinois-Urbana Research Park
1/20/2015 1:01:00 PM - Business Wire
▼-4.41 % Price Change since this news event. The Volume Ratio is 1.21.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AbbVie Announces U.S. FDA Approval of DUOPA™ (carbidopa and levodopa) Enteral Suspension for the Treatment of Motor Fluctuations in Patients with Advanced Parkinson''s Disease
1/16/2015 10:08:00 AM - PR Newswire


AbbVie Announces U.S. FDA Approval of DUOPA™ (carbidopa and levodopa) Enteral Suspension for the Treatment of Motor Fluctuations in Patients with Advanced Parkinson's Disease
1/16/2015 10:08:00 AM - PR Newswire
▼-4.35 % Price Change since this news event. The Volume Ratio is 1.03.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AbbVie to Host Fourth-Quarter and Full-Year 2014 Earnings Conference Call
1/16/2015 7:00:00 AM - PR Newswire
▼-4.26 % Price Change since this news event. The Volume Ratio is 1.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


European Commission Grants Marketing Authorizations for AbbVie''s VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) for the Treatment of Chronic Hepatitis C
1/16/2015 2:00:00 AM - PR Newswire


European Commission Grants Marketing Authorizations for AbbVie's VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) for the Treatment of Chronic Hepatitis C
1/16/2015 2:00:00 AM - PR Newswire
▼-4.26 % Price Change since this news event. The Volume Ratio is 0.97.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Prime Therapeutics Breaks from Competition, Strikes Deals to Prefer both Harvoni, Viekira Hepatitis C Drugs
1/12/2015 2:00:00 PM - PR Newswire


AbbVie Announces U.S. FDA Approval of DUOPA™ (carbidopa and levodopa) Enteral Suspension for the Treatment of Motor Fluctuations in Patients with Advanced Parkinson''s Disease
1/12/2015 8:00:00 AM - PR Newswire
▼-7.84 % Price Change since this news event. The Volume Ratio is 0.83.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Oxis Biotech Executes Worldwide Exclusive Patent Licensing "P62 Chemical Agents and Multiple Myeloma Therapeutics" with Dr. Xiang-Qun (Sean) Xie, Professor of Pharmaceutical Sciences at University of Pittsburgh
1/12/2015 7:30:00 AM - PR Newswire


BBCN Bancorp to Announce Fourth Quarter 2014 Financial Results on Monday, January 26, 2015
1/8/2015 5:07:00 PM - GlobeNewswire


AbbVie Issues Strong Outlook for 2015
1/8/2015 4:07:00 PM - PR Newswire
▼-11.47 % Price Change since this news event. The Volume Ratio is 1.36.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AbbVie Announces Positive Top-Line Results From Phase 3 Study of Investigational Medicine Elagolix in Patients with Endometriosis
1/8/2015 8:00:00 AM - PR Newswire
▼-9.71 % Price Change since this news event. The Volume Ratio is 1.39.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AbbVie to Present at 33rd Annual J.P. Morgan Healthcare Conference
12/30/2014 4:05:00 PM - PR Newswire
▼-8.75 % Price Change since this news event. The Volume Ratio is 0.72.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AbbVie to Present at Goldman Sachs Healthcare CEOs Unscripted Conference
12/23/2014 8:00:00 AM - PR Newswire
▼-9.96 % Price Change since this news event. The Volume Ratio is 1.47.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Express Scripts and AbbVie Make Hepatitis C Cure Available to Millions of Patients in Need
12/22/2014 7:00:00 AM - PR Newswire